Editorials Drugs for Alzheimer's disease and related dementias BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7496.857 (Published 14 April 2005) Cite this as: BMJ 2005;330:857 Article Related content Metrics Responses Peer review Related articles Editor's Choice Say no to the free lunch Published: 14 April 2005; BMJ 330 doi:10.1136/bmj.330.7496.0-g Paper Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial Published: 14 April 2005; BMJ 330 doi:10.1136/bmj.38369.459988.8F PAPERS Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial Published: 18 February 2005; BMJ doi:10.1136/bmj.38369.459988.8F See more Introductory Address Prov Med Surg J October 03, 1840, s1-1 (1) 1-4; DOI: https://doi.org/10.1136/bmj.s1-1.1.1 Report of the Meeting of the Eastern Branch of the Provincial Association at Bury St. Edmond's Prov Med Surg J October 03, 1840, s1-1 (1) 10-13; DOI: https://doi.org/10.1136/bmj.s1-1.1.10 Mr. Warburton's Bill for the Regulation of the Medical Profession Prov Med Surg J October 03, 1840, s1-1 (1) 13-15; DOI: https://doi.org/10.1136/bmj.s1-1.1.13 An Atlas of Plates, illustrative of the Principles and Practice of Obstetric Medicine and Surgery, with descriptive Letterpress Prov Med Surg J October 03, 1840, s1-1 (1) 4; DOI: https://doi.org/10.1136/bmj.s1-1.1.4 A Practical Treatise on the Diseases peculiar to Women, illustrated by Cases, &c Prov Med Surg J October 03, 1840, s1-1 (1) 4-5; DOI: https://doi.org/10.1136/bmj.s1-1.1.4-a Cited by... Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapyAbstract Fulltext PDF Clinical management of Parkinson's disease dementia: pitfalls and progressAbstract Fulltext PDF Which Drugs (or None) for Alzheimer Disease?Abstract Fulltext PDF Which Drugs (or None) for Alzheimer Disease?Abstract Fulltext PDF